Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review

Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A Review

The use of chemotherapy in premenopausal cancer patients may lead to chemotherapy-induced premature ovarian failure. Pharmacological temporary ovarian suppression obtained with the gonadotropin-releasing hormone agonist (GnRHa) administered concomitantly with chemotherapy has been investigated as a...

Full description

Bibliographic Details
Main Authors: Francesca Poggio, Matteo Lambertini, Claudia Bighin, Benedetta Conte, Eva Blondeaux, Alessia D’Alonzo, Chiara Dellepiane, Giulia Buzzatti, Chiara Molinelli, Francesco Boccardo, Lucia Del Mastro
Format: Article
Language:English
Published: SAGE Publishing 2019-07-01
Series:Clinical Medicine Insights: Reproductive Health
Online Access:https://doi.org/10.1177/1179558119864584

Internet

https://doi.org/10.1177/1179558119864584

Similar Items